Table 3. Evaluation of the pathogenic potential of variants.
Exon/Intron | cDNA change | Protein change | Known/Novel | Co-occurrence | SIFT MG | Polyphen-2 MG | AlignGVGD MGc | Proband ID | Family No. | Segregation ( + /−) | Final Prediction |
---|---|---|---|---|---|---|---|---|---|---|---|
PKD1 | |||||||||||
4 | c.464G > A | p.Cys155Tyr | PKDBa | B | N | N | G0599 | 43 | + | B | |
8 | c.1673C > T | p.Thr558Met | Novel | p.Ser3771SerfsX54 | N | N | N | G0017 | 39 | NA | E |
11 | c.2534T > C | p.Leu845Ser | PKDBa | p.Val951Ala | B | B | B | G0247 | 4 | + | B |
11 | c.2852T > C | p.Val951Ala | Novel | p.Leu845Ser | N | B | B | G0247 | 4 | — | D |
14 | c.3193C > A | p.His1065Pro | Novel | p.Asn3188Lys | N | C | N | G0122 | 8 | — | D |
15 | c.3548C > G | p.Ser1183Trp | Novel | p.Ser1457SerfsX64 | N | B | N | G0315 | 9 | NA | E |
15 | c.3955G > A | p.Gly1319Arg | 16 a | B | B | B | G0210 | 16 | + | B | |
15 | c.5824C > T | p.Arg1942Cys | Novel | C | C | C | G0240 | 7 | + | C | |
15 | c.6496C > T | p.Arg2166Cys | PKDBb | p.Thr2720del | C | B | I | G0001, G0649 | 12,44 | NA — | I |
17 | c.7132G > A | p.Val2378Met | Novel | p.Val1971GlufsX17 | N | B | N | G1052 | 48 | — | E |
18 | c.7214G > T | p.Trp2405Leu | Novel | B | C | C | G0255 | 2 | + | C | |
22 | c.8157—8159delCAC | p.Thr2720del | Novel | p.Arg2166Cys | G0649 | 44 | + | B | |||
23 | c.8294G > A | p.Arg2765His | Novel | N | N | N | G0676 | 56 | NA | E | |
23 | c.8311G > A | p.Glu2771Lys | PKDBa | C | B | C | G0212 | 18 | + | B | |
25 | c.9136C > T | p.Arg3046Cys | Novel | p.Tyr3819Asn | B | C | C | G0241 | 6 | NA | C |
27 | c.9564C > G | p.Asn3188Lys | Novel | p.His1065Pro | B | B | B | G0122 | 8 | + | C |
IVS32 | c.10220+2T > C | Novel | p.Thr4018Ile | Possibly affecting the splice site | G1410 | 38 | + | B | |||
IVS35 | c.10618+1delG | Novel | Possibly affecting the splice site | G0053 | 10 | + | B | ||||
41 | c.11455T > A | p.Tyr3819Asn | Novel | p.Arg3046Cys | B | C | N | G0241 | 6 | NA | D |
44 | c.12053C > T | p.Thr4018Ile | Novel | c.10220 + 2T > C | C | B | I | G1410 | 38 | — | I |
PKD2 | |||||||||||
1 | c.17G > A | p.Arg6His | Novel | Exon1del | B | N | N | G0677 | 30 | — | E |
8 | c.1796G > A | p.Gly599Asp | Novel | B | C | B | G0976 | 47 | + | C |
Abbreviations: ID, identification; NA, not analysed; MG, mutation group; PKDB, PKD mutation database; B: highly likely pathogenic; C: likely pathogenic; I: indeterminate; N: neutral; D: likely polymorphic; E: polymorphic.
aThe mutation has been previously classified to be “highly likely pathogenic”.
bThe mutation has been previously classified to be “indeterminate”.
cPolycystin orthologue alignment (human, mouse, rat, chicken, X. tropicalis, fugu, dog, opossum and tetraodon).